Clinical Trials · NCT00081458

Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome

CompletedPhase 3Teduglutide (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Shire
Enrollment
84
Start date
May 2004
Locations
32 sites, 9 countries
Primary endpoint
A Graded Response Score in Parenteral Nutrition (PN) Reduction
View Teduglutide compound reference